Consistent with previous reports that cancer cells often exhibit defective ER stress signaling [20], we found that thapsigargin (TG) treatment enhanced IRE1α and PKAc phosphorylation and upregulated XBP1 target genes such as YBX2 and TGFβ2. The gene discussed is XBP1; the disease is cancer.